Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study
Abstract Background Persons with opioid use disorders (OUD) and persons with substance use disorders (SUD) who inject substances have a reduced life expectancy of up to 25 years compared with the general population. Chronic liver diseases are a substantial cause of this. Screening strategies based o...
Saved in:
Main Authors: | Karl Trygve Druckrey-Fiskaaen (Author), Jørn Henrik Vold (Author), Tesfaye Madebo (Author), Håvard Midgard (Author), Olav Dalgard (Author), Rafael Alexander Leiva (Author), Lars T. Fadnes (Author), for the INTRO-HCV Study Group (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The association of psychological distress and economic and health worries with tobacco smoking behavior during the COVID-19 pandemic: a two-year longitudinal cohort study
by: Silvia Eiken Alpers, et al.
Published: (2024) -
A qualitative study of experiences with physical activity among people receiving opioid agonist therapy
by: Einar Furulund, et al.
Published: (2024) -
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020
by: Jørn Henrik Vold, et al.
Published: (2020) -
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
by: Christer Frode Aas, et al.
Published: (2021) -
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
by: Christer Frode Aas, et al.
Published: (2020)